Orforglipron is an oral, small-molecule, non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist. As a selective allosteric modulator, it is primarily indicated for the management of obesity and type… Read more


























![Chemical structure of rel-3-((1R,2R)-1-(5-((R)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-2-((R)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(2H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3109326-79-3-rel-3-1R2R-1-5-R-22-Dimethyltetrahydro-2H-pyran-4-yl-2-R-3-3-4-fluoro-1-methyl-1H-indazol-5-yl-2-oxo-23-dihydro-1H-imidazol-1-yl-2-4-fluo.png&w=3840&q=75)


![Chemical structure of tert-Butyl (R)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-R-2-4-fluoro-35-dimethylphenyl-4-methyl-3-2-oxo-23-dihydro-1H-imidazol-1-yl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-2-(3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-2-35-dimethylphenyl-4-methyl-3-2-oxo-23-dihydro-1H-imidazol-1-yl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-2-(4-bromo-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-2-4-bromo-35-dimethylphenyl-4-methyl-3-2-oxo-23-dihydro-1H-imidazol-1-yl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-2-(4-fluoro-3,5-dimethylphenyl)-3-((R)-4-hydroxy-2-oxoimidazolidin-1-yl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-2-4-fluoro-35-dimethylphenyl-3-R-4-hydroxy-2-oxoimidazolidin-1-yl-4-methyl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-2-(4-fluoro-3,5-dimethylphenyl)-3-((S)-4-hydroxy-2-oxoimidazolidin-1-yl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-2-4-fluoro-35-dimethylphenyl-3-S-4-hydroxy-2-oxoimidazolidin-1-yl-4-methyl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2212021-61-7-tert-Butyl-S-2-4-fluoro-35-dimethylphenyl-4-methyl-3-2-oxo-23-dihydro-1H-imidazol-1-yl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxyl.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3'-amino-2'-(4-fluoro-3,5-dimethylphenyl)-4'-methyl-2',4'-dihydrospiro[cyclobutane-1,7'-pyrazolo[4,3-c]pyridine]-5'(6'H)-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-3-amino-2-4-fluoro-35-dimethylphenyl-4-methyl-24-dihydrospirocyclobutane-17-pyrazolo43-cpyridine-56H-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3'-amino-2'-(4-fluoro-3,5-dimethylphenyl)-4'-methyl-2',4'-dihydrospiro[cyclopentane-1,7'-pyrazolo[4,3-c]pyridine]-5'(6'H)-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3084716-10-6-tert-Butyl-S-3-amino-2-4-fluoro-35-dimethylphenyl-4-methyl-24-dihydrospirocyclopentane-17-pyrazolo43-cpyridine-56H-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3'-amino-2'-(4-fluoro-3,5-dimethylphenyl)-4'-methyl-2',4'-dihydrospiro[cyclopropane-1,7'-pyrazolo[4,3-c]pyridine]-5'(6'H)-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3084715-65-8-tert-Butyl-S-3-amino-2-4-fluoro-35-dimethylphenyl-4-methyl-24-dihydrospirocyclopropane-17-pyrazolo43-cpyridine-56H-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3'-amino-2'-(4-fluoro-3,5-dimethylphenyl)-4'-methyl-2',4'-dihydrospiro[oxetane-3,7'-pyrazolo[4,3-c]pyridine]-5'(6'H)-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3084716-01-5-tert-Butyl-S-3-amino-2-4-fluoro-35-dimethylphenyl-4-methyl-24-dihydrospirooxetane-37-pyrazolo43-cpyridine-56H-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3'-amino-2'-(4-fluoro-3,5-dimethylphenyl)-4'-methyl-2,2',3,4',5,6-hexahydrospiro[pyran-4,7'-pyrazolo[4,3-c]pyridine]-5'(6'H)-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3084715-74-9-tert-Butyl-S-3-amino-2-4-fluoro-35-dimethylphenyl-4-methyl-223456-hexahydrospiropyran-47-pyrazolo43-cpyridine-56H-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3-(3-(2,2-dimethoxyethyl)ureido)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2212021-60-6-tert-Butyl-S-3-3-22-dimethoxyethylureido-2-4-fluoro-35-dimethylphenyl-4-methyl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3-(3-(tert-butoxycarbonyl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-3-3-tert-butoxycarbonyl-2-oxo-23-dihydro-1H-imidazol-1-yl-2-4-fluoro-35-dimethylphenyl-4-methyl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3-amino-2-(3,5-dimethylphenyl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-3-amino-2-35-dimethylphenyl-4-methyl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3-amino-2-(4-chloro-3,5-dimethylphenyl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-3-amino-2-4-chloro-35-dimethylphenyl-4-methyl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3-amino-2-(4-fluoro-3,5-dimethylphenyl)-4,7,7-trimethyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-3-amino-2-4-fluoro-35-dimethylphenyl-477-trimethyl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-3-amino-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2212021-59-3-tert-Butyl-S-3-amino-2-4-fluoro-35-dimethylphenyl-4-methyl-2467-tetrahydro-5H-pyrazolo43-cpyridine-5-carboxylate.png&w=3840&q=75)

Orforglipron is an oral, small-molecule, non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist. As a selective allosteric modulator, it is primarily indicated for the management of obesity and type 2 diabetes mellitus, where it enhances glucose-dependent insulin secretion and helps regulate food intake. This category provides an essential collection of reference standards, including synthetic intermediates, degradation products, and metabolites, necessary for the comprehensive analytical characterization of the active pharmaceutical ingredient. Pharmaceutical laboratories utilize these materials for rigorous impurity profiling and method validation, ensuring high-quality standards in drug development. Additionally, stable isotope labelled compounds are available to serve as internal standards in complex bioanalytical assays. These high-purity materials support researchers and quality control departments in identifying, quantifying, and controlling impurities throughout the drug lifecycle, facilitating the development of stable and consistent pharmaceutical formulations.